c="beta 75 Leu" 1:11 1:13||t="medication"||cui="C0023401"||tot="Leucine"||ns="-827"
c="beta 141 Leu" 1:15 1:17||t="medication"||cui="C0023401"||tot="Leucine"||ns="-827"
c="Reverse phase HPLC analysis" 2:0 2:3||t="test"||cui="C0002778"||tot="Analysis of substances"||ns="-812"
c="hemolytic anemia" 2:11 2:12||t="problem"||cui="C0002878"||tot="Anemia, Hemolytic"||ns="-1000"
c="Reverse phase Peptide mapping" 2:21 2:24||t="test"||cui="C0030944"||tot="Peptide Mapping"||ns="-861"
c="beta 75 Leu" 2:41 2:43||t="medication"||cui="C0023401"||tot="Leucine"||ns="-827"
c="contained two mutations beta 75 Leu" 2:50 2:55||t="medication"||cui="C0023401"||tot="Leucine"||ns="-799"
c="beta 141 Leu" 2:57 2:59||t="medication"||cui="C0023401"||tot="Leucine"||ns="-827"
